1 Matsuyama R, "Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer" 24 : 3490-3349, 2006
2 Crown JP, "The platinum agents: a role in breast cancer treatment?" 28 : 28-37, 2001
3 Bartelink H, "The combined use of radiotherapy and chemotherapy in the treatment of solid tumours" 38 : 216-222, 2002
4 Kanadaswami C, "The antitumor activities of flavonoids" 19 : 895-909, 2005
5 Lambert JD, "The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention" 501 : 65-72, 2010
6 Kazi A, "Potential molecular targets of tea polyphenols in human tumor cells: significance in cancer prevention" 16 : 397-403, 2002
7 Gupta S, "Molecular pathway for (-)-epigallocatechin-3-gallate-induced cells cycle arrest and apoptosis of human prostate carcinoma cells" 410 : 177-185, 2003
8 Jordan P, "Molecular mechanisms involved in cisplatin cytotoxicity" 57 : 1229-1235, 2000
9 Samad A, "Liposomal drug delivery systems: an update review" 4 : 297-305, 2007
10 Jun YD, "Inhibition of tumour invasion and angiogenesis by epigallocatechin galltae (EGCG), a major component of green tea" 82 : 309-316, 2001
1 Matsuyama R, "Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer" 24 : 3490-3349, 2006
2 Crown JP, "The platinum agents: a role in breast cancer treatment?" 28 : 28-37, 2001
3 Bartelink H, "The combined use of radiotherapy and chemotherapy in the treatment of solid tumours" 38 : 216-222, 2002
4 Kanadaswami C, "The antitumor activities of flavonoids" 19 : 895-909, 2005
5 Lambert JD, "The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention" 501 : 65-72, 2010
6 Kazi A, "Potential molecular targets of tea polyphenols in human tumor cells: significance in cancer prevention" 16 : 397-403, 2002
7 Gupta S, "Molecular pathway for (-)-epigallocatechin-3-gallate-induced cells cycle arrest and apoptosis of human prostate carcinoma cells" 410 : 177-185, 2003
8 Jordan P, "Molecular mechanisms involved in cisplatin cytotoxicity" 57 : 1229-1235, 2000
9 Samad A, "Liposomal drug delivery systems: an update review" 4 : 297-305, 2007
10 Jun YD, "Inhibition of tumour invasion and angiogenesis by epigallocatechin galltae (EGCG), a major component of green tea" 82 : 309-316, 2001
11 Cersosimo RJ, "Hepatotoxicity associated with cisplatin chemotherapy" 27 : 438-441, 1993
12 Thangapazham RL, "Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo" 245 : 232-241, 2007
13 Silverberg JI, "Green tea extract protects human skin fibroblasts from reactive oxygen species induced necrosis" 10 : 1096-1101, 2011
14 Yang CS, "Green tea and cancer prevention" 62 : 931-937, 2010
15 Rao SD, "Epigallocatechin-3-gallate, a natural polyphenol, inhibits cell proliferation and induces apoptosis in human ovarian cancer cells" 30 : 2519-2523, 2010
16 Chan MM, "Epigallocatechin-3-gallate delivers hydrogen peroxide to inducedeath of ovarian cancer cells and enhances their cisplatinsusceptibility" 207 : 389-396, 2006
17 Sladowski D, "An improved MTT assay" 157 : 203-207, 1993
18 Di Stefano G, "A conjugate of doxorubicin with lactosaminated albumin enhances the drug concentrations in all the forms of rat hepatocellular carcinomas independently of their differentiation grade" 26 : 726-733, 2006